Argipressine

Argipressine 구조식 이미지
카스 번호:
113-79-1
상품명:
Argipressine
동의어(영문):
ARGININE VASOPRESSIN;argipressin;AVP;ANTIDIURETIC HORMONE;argipressine;Argipression;β-Hypophamine;Arg-Vasopressin;BETA-HYPOPHAMINE;[ARG8]-VASOPRESSIN
CBNumber:
CB9205622
분자식:
C46H65N15O12S2
포뮬러 무게:
1084.24
MOL 파일:
113-79-1.mol

Argipressine 속성

밀도
1.59±0.1 g/cm3(Predicted)
인화점
113℃
저장 조건
2-8°C
산도 계수 (pKa)
9.90±0.15(Predicted)
수소이온지수(pH)
~3.5
수용성
Water : ≥ 360 mg/mL (332.03 mM)
시퀀스
H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,(Disulfide bond)
InChIKey
KBZOIRJILGZLEJ-KIIOGHSHNA-N
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn
위험 카페고리 넘버 20
안전지침서 36
WGK 독일 3
HS 번호 2937190000
독성 TDLo ivn-pig: 40 ng/kg JPETAB 293,852,2000
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H332 흡입하면 유해함 급성 독성 물질 흡입 구분 4 경고 GHS hazard pictograms P261, P271, P304+P340, P312
예방조치문구:
P261 분진·흄·가스·미스트·증기·...·스프레이의 흡입을 피하시오.

Argipressine C화학적 특성, 용도, 생산

용도

Hormone (antidiuretic).

정의

ChEBI: The predominant form of mammalian vasopressin (antidiuretic hormone). It is a nonapeptide containing an arginine at residue 8 and two disulfide-linked cysteines at residues of 1 and 6.

Indications

ADH (vasopressin) is released primarily in response to increases in plasma osmolarity or decreases in blood volume. It produces its antidiuretic activity in the kidney, causing the cortical and medullary parts of the collecting duct to become more permeable to water, thereby increasing water reabsorption, reducing serum osmolarity, and increasing its volume. It produces this effect by binding to a subset of vasopressin receptors called V2 that have relatively high affinity for the hormone. ADH also has actions at sites other than the kidney. V2 receptors also mediate an increase in circulating levels of two proteins involved in blood coagulation: factor VIII and von Willebrand’s factor.At higher concentrations, ADH interacts with V1 receptors to cause a general constriction of most blood vessels. It also interacts with V3 (or V1b) receptors to increase ACTH release, although the major control of ACTH release occurs through corticotropin-releasing hormone.

일반 설명

Vasopressin tannate (PitressinTannate) is a water-insoluble tannate of vasopressin administeredintramuscularly (1.5–5.0 pressor units daily)for its prolonged duration of action by the slow release ofvasopressin. It is particularly useful for patients who havediabetes insipidus, but it should never be used intravenously.

위험도

A poison.

Mechanism of action

ADH itself is available for injections (Pitressin) but has a half-life of about 15 minutes. Desmopressin (DDAVP) is an analogue without an amino group at the first amino acid and with D-arginine instead of Larginine. This analogue is more stable and has very little pressor activity. Desmopressin can be given subcutaneously or nasally, and the effects last for 12 hours.

Clinical Use

Because it is stable, desmopressin is preferred for treatments especially if pressor effects are not desired. The primary indication for therapy is central diabetes insipidus, a disorder that results when ADH secretion is reduced and that is characterized by polydipsia, polyuria, and dehydration. Desmopressin is also used to reduce primary nocturnal enuresis, or bedwetting, in children. It is useful in people with mild hemophilia A or with some types of von Willebrand’s disease, in which von Willebrand’s factor is present at low levels. In these cases, desmopressin is given when excessive bleeding occurs or before surgery to help reduce bleeding indirectly by increasing the amounts of coagulation factors. A possible adverse effect of desmopressin is water intoxication if too much is taken.
ADH antagonists, including nonpeptide analogues that may be taken orally, have been developed with specificity for each of the receptor types. In the future, those that block V1 receptors may be useful in treating hypertension, and those that block V2 receptors may be useful in any condition of excessive water retention or hyponatremia, for which so far there is no satisfactory therapeutic treatment.

Safety Profile

A poison by intravenous route.When heated to decomposition it emits toxic vapors ofNOx and SOx.

Argipressine 준비 용품 및 원자재

원자재

준비 용품


Argipressine 공급 업체

글로벌( 330)공급 업체
공급자 전화 이메일 국가 제품 수 이점
GIHI CHEMICALS CO.,LIMITED
+8618058761490
info@gihichemicals.com China 49999 58
Zhejiang Hangyu API Co., Ltd
+8617531972939
anna@api-made.com China 2944 58
Shanghai Chinqesen Biotechnology Co., Ltd.
+86-16628886292 +86-19521323435
sales2@qschem-pharma.com China 46 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12453 58
Shanghai Yunao International Trade Co., Ltd
+8617621705551
asdf@shanghaihg.cn China 265 58
Henan Tengmao Chemical Technology Co. LTD
+8615238638457
salesvip2@hntmhg.com China 415 58
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2503 58
qingdao future trading Co., Ltd
+86-13335044410 +86-13335044410
cui56813@163.com China 110 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 11013 58
Shandong Huisheng Import & Export Co., Ltd.
+86-13176845580 +86-13176845580
da@zhongda-biotech.com China 248 58

Argipressine 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved